Long‐term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®‐ON

BACKGROUND AND OBJECTIVE: The efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis (IPF) were investigated in the placebo‐controlled INPULSIS® trials. All patients who completed an INPULSIS® trial could receive open‐label nintedanib in the extension trial INPULSIS®‐ON. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jin Woo, Ogura, Takashi, Inoue, Yoshikazu, Xu, Zuojun, Quaresma, Manuel, Stowasser, Susanne, Stansen, Wibke, Crestani, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154738/
https://www.ncbi.nlm.nih.gov/pubmed/31329360
http://dx.doi.org/10.1111/resp.13647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154738/
https://www.ncbi.nlm.nih.gov/pubmed/31329360
http://dx.doi.org/10.1111/resp.13647

Ejemplares similares